Abstract
In Drosophila, pole cells, the progenitors of the germ line, are induced by the factors localized in the posterior pole region of oocytes and cleavage embryos, or germ plasm. Polar granules in germ plasm are electron-dense structures and have been proposed to contain factors essential for pole cell formation. Mitochondrially encoded large ribosomal RNA (mtlrRNA) has been identified as a component of polar granules. We previously have shown that mtlrRNA is able to rescue embryos that fail to form pole cells as a result of UV irradiation. However, there is a possibility that the function of mtlrRNA is limited to UV-irradiated embryos, and the question of whether mtlrRNA is required for the normal pathway leading to pole cell formation remains unanswered. In this study, we report that the reduction of mtlrRNA in germ plasm by injecting anti-mtlrRNA ribozymes into cleavage embryos leads to their inability to form pole cells. Other components of germ plasm, namely oskar mRNA, germ cell-less mRNA, and Vasa and Tudor proteins appear to be unaffected in these ribozyme-injected embryos. These results support an essential role for mtlrRNA in pole cell formation. We propose that mitochondrially encoded molecules participate in a key event in early cell-type specification.
How the germ line segregates from the soma is a century-old issue in cell and developmental biology. In many animal species, the factor required for germ-line establishment has been postulated to be localized in a histologically distinct region in egg cytoplasm or germ plasm (1, 2). Experimental studies with frogs and the fruit fly Drosophila have demonstrated that factors with sufficient ability to establish germ line are localized in germ plasm (3–5). In Drosophila, germ plasm is localized at the posterior pole region of oocytes and cleavage embryos. It is this polar plasm that is later partitioned into pole cells, the progenitors of germ line in this animal (6). Distinctive organelles in polar plasm are polar granules, which are composed of RNAs and proteins (7). Protein products encoded by some maternally acting genes, namely oskar (osk), vasa (vas), and tudor (tud), have been reported as components of polar granules (8–10). The activities of all of these genes are required for polar granule assembly as well as pole cell formation (11–13), suggesting that the granules are essential for pole cell formation.
Ultrastructural studies have revealed that the polar granules are closely associated with mitochondria at definite stages before pole cell formation (14). This finding raises the possibility that mitochondria might contribute to pole cell formation, along with nuclear products. We previously have reported that one of the components in polar granules is mitochondrially encoded large ribosomal RNA (mtlrRNA) (15, 16). MtlrRNA is enriched on polar granules during early embryonic stages before pole cell formation, and its localization depends on the function of osk, vas, and tud (refs. 15–17; R. Amikura, M. Kashikawa and S.K., unpublished work). Because mtlrRNA is exclusively encoded by the mitochondrial genome, this observation indicates that mtlrRNA is transported out of mitochondria to reach polar granules in polar plasm. Based on these findings, we proposed that the extra-mitochondrial mtlrRNA on polar granules is a candidate for a factor directing pole cell formation. Further evidence supporting this idea comes from our data that mtlrRNA is able to rescue embryos from the failure to form pole cells by UV irradiation (18). However, there is a possibility that the function of mtlrRNA is limited to UV-irradiated embryos, and the question of whether mtlrRNA is required for the normal pathway leading to pole cell formation remains unanswered.
In Drosophila, genetic approaches are especially useful to assess the function of nuclear genes, but are unavailable to manipulate the mitochondrial genome. To overcome this problem, we used hammerhead ribozymes to specifically reduce or eliminate mtlrRNA. Hammerhead ribozyme is catalytic RNA that can cleave specific RNAs by hybridizing complementary target sequences (19, 20). The resulting RNA fragments are degraded, rendering the target molecules nonfunctional. Targeted ribozymes have been used as tools to create functional knockouts in various systems and provide an alternative to genetic strategies (21–30). Here, we report that the reduction of mtlrRNA in germ plasm by injecting anti-mtlrRNA ribozymes into cleavage embryos leads to their inability to form pole cells.
MATERIALS AND METHODS
Ribozyme Constructs.
Synthetic double-stranded oligonucleotides containing the anti-mtlrRNA ribozyme sequences, 5′-ATTACGCTGTCTGATGAGTCCGTGAGGACGAAATCCCTAAAGT-3′ (RbzJ) and 5′-TTATCGATATCTGATGAGTCCGTGAGGACGAAAACTCTCCAAA-3′ (RbzK) (underlined sequences are complementary to the mtlrRNA target sequences) (31) were inserted individually into the SalI and XbaI sites of a modified pGEM7Zf(−) vector (kindly provided by L. Pick, Mount Sinai School of Medicine) containing 65-bp fragment from Escherichia coli lacZ gene (30). Similarly, the double-stranded oligonucleotides containing ribozyme sequences, 5′-TGACTCGCACCTGATGAGTCCGTGAGGACGAAAGCCGCTGCCG-3′ (Rbz2), 5′-AGCTGGGCAGCTGATGAGTCCGTGAGGACGAAATTGCGGCCCA-3′(Rbz3), and 5′-CTGGAATTGGCTGATGAGTCCGTGAGGACGAAAGCTCCGCGCA-3′ (Rbz4) (underlined sequences are complementary to the nanos mRNA sequences, but not to mtlrRNA) were inserted individually into the modified pGEM7Zf(−) vector. Then, a 186-nt poly(A) sequence was inserted into the XbaI site downstream of the ribozyme sequence and used as a template for in vitro transcription of the ribozymes. The ribozymes were transcribed from the template DNA by using a MEGAscript kit (Ambion). m7G(5′)ppp(5′)G cap analog (Ambion) was added to the ribozymes during in vitro transcription according to the manufacturer’s instructions. Transcribed ribozymes were dissolved in distilled water (DW) and stored at −80°C until use.
We found that both RbzJ and RbzK cleaved mtlrRNA at the expected sites in vitro. 32P-labeled mtlrRNA (10 nM) and 100 nM 32P-labeled anti-mtlrRNA RbzJ and RbzK were incubated in 20 μl of a reaction solution (50 mM Tris⋅HCl, pH 8.0 and 25 mM MgCl2) for 1 hr at 37°C. Then, 3 μl of reaction solution was loaded on a 5% denaturing polyacrylamide gel containing 7 M urea and electrophoresed. The cleaved mtlrRNA fragments were detected by autoradiography (data not shown). In contrast, neither Rbz2, Rbz3, or Rbz4 was unable to cleave mtlrRNA in a similar reaction condition (data not shown).
Microinjection Experiments.
For microinjection experiments, embryos of a mwh e11 stock were used. Microinjection method was principally the same as previously reported (32). A mixture (0.1 nl) of RbzJ and RbzK (9 μM each) was injected into the posterior pole region of mwh e11 embryo at 20 ± 10 min after egg laying. As a control, 0.1 nl of a mixture (Rbz mix) of Rbz2, Rbz3, and Rbz4 (10 μM each) was injected. In situ hybridization analysis revealed that the injected ribozymes remained to be enriched in polar plasm within at least 30 min after the microinjection. The injected embryos were allowed to develop for 20–25 min at 25°C, then were fixed for in situ hybridization and/or immunostaining. For scoring pole cell formation, the injected embryos were allowed to develop in silicon oil (FL-100 450CS, SHIN-ETSU silicon oil) at 25°C until 3 hr after egg laying, and then were observed under a light microscope.
In Situ Hybridization for Electron Microscopy.
Subcellular distribution of the injected ribozymes was examined by using in situ hybridization technique at an electron microscopic level as previously described (33). After the injection of RbzJ and RbzK into the posterior pole region of the cleavage embryos, the embryos were processed for fixation, embedding, ultra-thin sectioning, and in situ hybridization with a double-stranded digoxigenin (DIG)-labeled DNA (205 bp) encoding RbzJ and RbzK. We counted the number of signals in the area of 15 μm2 in polar plasm of the ribozyme-injected embryos.
In Situ Hybridization for Light Microscopy and Immunohistochemistory.
Whole-mount in situ hybridization using a double-stranded DIG-labeled DNA probe was carried out principally according to the method reported by Tautz and Preifle (34). A full-length 1,446-bp mtlrRNA cDNA (31), 2,432-bp osk cDNA, 2,388-bp gcl cDNA, and 1,725-bp bcd cDNA were DIG-labeled and used as probes for in situ hybridization.
Immunostaining for VAS and TUD protein was carried out according to the method previously reported (35). We used a rabbit anti-VAS antibody (a gift from A. Nakamura and P. Lasko, McGill University, Montreal) and a rabbit anti-TUD antibody (a gift from R. Boswell, University of Colorado). Texas Red-conjugated goat anti-rabbit IgG (Amersham) and fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Cappel) were used as secondary antibodies. The stained embryos were mounted in VECTASHIELD Mounting Medium (Vector) and were observed under a confocal microscope, TCS NT (Leica).
RESULTS AND DISCUSSION
We constructed two targeted ribozymes (RbzJ and RbzK), which were designed to hybridize with residues 1064–1085 and 1089–1110 of 1,324-bp mtlrRNA, respectively. Comparison of the nucleotide sequences in these targets with those of nuclear large (28S) rRNA and mRNAs known to be localized in polar plasm revealed no significant homology. In addition, we have searched homologous sequences in the Drosophila DNA database (the Berkley fly database) but found no sequence showing more than 68% homology with the target sequences. This finding suggests that RbzJ and RbzK are unable to hybridize these RNA sequences. By hybridizing mtlrRNA, RbzJ and RbzK were designed to cleave it at nucleotides 1075 and 1100, respectively. Each of these ribozymes cleaved it in vitro at the expected position (data not shown).
We investigated whether these anti-mtlrRNA ribozymes were able to reduce or eliminate mtlrRNA in polar plasm. To increase efficiency, we coinjected both anti-mtlrRNA ribozymes into the posterior pole region of early cleavage embryos (20 ± 10 min after egg laying). In situ hybridization analysis revealed that coinjection of RbzJ and RbzK caused a drastic reduction of mtlrRNA signal in polar plasm (Fig. 1B). In 17.3% of the injected embryos, mtlrRNA signal decreased to an undetectable level, whereas only 7.3% of the control embryos that had been injected with DW failed to show the posterior localization of mtlrRNA signal (Table 1). Furthermore, injection of control ribozymes that did not cleave mtlrRNA in vitro had no deleterious effect on the posterior localization of mtlrRNA signal (Table 1). Considering that the in situ hybridization technique used here is able to detect mtlrRNA only outside of mitochondria (33), these results indicate that the amount of extra-mitochondrial mtlrRNA decreases significantly by the injection of the anti-mtlrRNA ribozymes. In contrast, these ribozymes fail to target intra-mitochondrial mtlrRNA because the ribozymes injected into polar plasm were indiscernible in mitochondria. Under an electron microscope, we counted the number of signals in the area of 15 μm2 in polar plasm of the ribozyme-injected embryos that were in situ-hybridized with ribozyme probes. All signals (total number of signals = 51) were found only in the cytosol outside of mitochondria. Presumably, this is caused by the impermeability of mitochondrial membrane to nucleic acids.
Table 1.
Injected materials | Total no. of embryos scored* | No. of embryos without mtlrRNA signal in polar plasm†, % | Significance |
---|---|---|---|
RbzJ & K | 300 | 52 (17.3) | P < 0.001§ P < 0.001¶ |
DW | 262 | 19 (7.3) | |
Control | |||
Rbz mix‡ | 124 | 5 (4.0) | P > 0.2§ |
DW | 83 | 5 (6.0) |
The injected embryos were in situ-hybridized with mtlrRNA probe. As an internal control for in situ hybridization, the embryos also were hybridized with a DIG-labeled probe detecting bcd mRNA that localizes at the anterior pole region of early embryos. Furthermore, to exclude embryos in which polar plasm leaked out or was delocalized by the injection procedure, the injected embryos were stained with an antibody against VAS protein. Neither the anterior localization of bcd nor the posterior localization of VAS was affected by the injection of anti-mtlrRNA ribozymes. The number of embryos without mtlrRNA signal was determined from embryos that showed normal bcd and VAS staining.
Whole-mount in situ hybridization of the ribozyme-injected embryos using a double-stranded DNA probe for mtlrRNA.
A mixture of ribozymes that did not cleave mtlrRNA was injected into embryos.
Probability was calculated vs DW-injected embryos by Fisher’s exact probability test.
¶ Probability was calculated vs control Rbz mix-injected embryos by Fisher’s exact probability test.
To exclude the possibility that RNA components of polar plasm are degraded nonspecifically by the injected ribozymes, we further examined distribution of two other RNAs localized in polar plasm, osk mRNA, and germ cell-less (gcl) mRNA (36), and found that the amount of these RNAs was unaffected (Table 2, Fig. 1 C and D). In addition, the posterior concentration of other polar plasm components, Vasa (VAS) and Tudor (TUD) proteins, appeared to be unaffected in these embryos (Table 2, Fig. 1 E and F). These results indicate that anti-mtlrRNA ribozymes specifically reduce the amount of extra-mitochondrial mtlrRNA in polar plasm.
Table 2.
RNAs and proteins detected* | Rbzs† | Total no. of embryos scored | No. of embryos without signal in polar plasm, % | Significance‡ |
---|---|---|---|---|
gcl | + | 324§ | 6 (1.9) | P > 0.2 |
− | 320§ | 9 (2.8) | ||
osk | + | 296¶ | 0 (0) | P > 0.2 |
− | 239¶ | 1 (0.4) | ||
VAS | + | 1,042‖ | 73 (7.0) | P > 0.2 |
− | 944‖ | 66 (7.0) | ||
TUD | + | 300** | 13 (4.2) | P > 0.2 |
− | 313** | 18 (5.8) |
Whole-mount in situ hybridization of the ribozyme-injected embryos using a double-stranded DNA probe for mtlrRNA, osk and gcl mRNA was performed. Immunostaining for VAS and TUD protein was carried out.
Embryos were injected with the anti-mtlrRNA ribozymes (+) or DW (−).
Probability was calculated vs DW-injected embryos by Fisher’s exact probability test.
The injected embryos were stained with gcl probe. To exclude embryos in which polar plasm leaked out or was delocalized by the injection procedure, the injected embryos were stained with an antibody against VAS protein. The number of embryos without gcl signal was counted among the embryos that showed normal VAS staining.
¶ The injected embryos were stained with osk probe. As an internal control for in situ hybridization, the embryos also were hybridized with a DIG-labeled probe detecting bcd mRNA that localizes at the anterior pole region of early embryos. And the injected embryos also were immunostained with an anti-VAS antibody. The number of embryos without osk signal was counted among the embryos that showed normal bcd and VAS staining.
The injected embryos were immunostained with an anti-VAS antibody. The number of embryos without VAS signal was counted among the injected embryos.
The injected embryos were immunostained with an anti-TUD antibody. The number of embryos without TUD signal was counted among the injected embryos.
To examine whether pole cell formation is affected by the reduction of mtlrRNA in polar plasm, we allowed the ribozyme-injected embryos to develop to blastoderms and observed their cellularization under the light microscope. These embryos formed normal-looking blastodermal layers of somatic cells and proceeded through gastrulation. However, as shown in Table 3 and Fig. 2, their ability to form pole cells was significantly reduced. In 13.4% of the ribozyme-injected embryos, pole cells were missing. In contrast, only 1.5% of the DW-injected embryos developed to blastoderms without pole cells. Furthermore, injection of the control ribozymes that did not affect the posterior localization of mtlrRNA (Table 1) failed to inhibit pole cell formation (Table 3). These results clearly show that pole cell formation is impaired in embryos only when injected with the anti-mtlrRNA ribozymes. It is worthwhile to note that the percentage of embryos whose pole-cell-forming ability is impaired by the injection of the anti-mtlrRNA ribozymes is similar to that of embryos showing a strong reduction in the posterior concentration of extra-mitochondrial mtlrRNA.
Table 3.
Injected materials | No. of embryos developed to blastoderms
|
Significance† | |
---|---|---|---|
Total | Without pole cells (%)* | ||
RbzJ & K | 2,861 | 382 (13.4) | P < 0.001 |
DW | 2,029 | 30 (1.5) | |
Control | |||
Rbz mix‡ | 175 | 1 (0.6) | P > 0.2 |
DW | 89 | 1 (1.1) |
The injected embryos were allowed to developed to cellular blastoderms at 25°C, then were observed under the light microscope. We found that a few percentages of the ribozyme-injected embryos formed only a small number of pole cells, which we classified as the embryos with pole cells.
Probability was calculated vs DW-injected embryos by Fisher’s exact probability test.
A mixture of ribozymes that did not cleave mtlrRNA was injected into embryos.
The above results, along with our previous UV rescue experiments (18), lead to the conclusion that mtlrRNA is a functional component of polar granules and is essential for pole cell formation. This finding supports the idea that mitochondrially encoded molecule participates in a key event in early cell-type specification. There is a further question of how mtlrRNA directs the formation of pole cells. MtlrRNA has no long ORF and is unable to be translated into protein in rabbit reticulocyte lysate (Y. Uozumi and S.K., unpublished material), suggesting that mtlrRNA functions without being translated. However, a structural role for mtlrRNA in which it functions to stabilize or tether the polar granule components is unlikely. Even when mtlrRNA decreased to an undetectable level by the injection of the anti-mtlrRNA ribozymes, the polar granule components were properly localized in polar plasm (Table 2). Recently, we found that mitochondrial small rRNA also was transported from mitochondria to polar granules before pole cell formation, and its transport depended on the normal activities of osk, vas, and tud (M. Kashikawa and S.K., unpublished work). This observation leads us to speculate that there are mitochondrial ribosomes on polar granules and their function is needed to produce proteins required for pole cell formation. This idea is compatible with early models that mRNAs encoding proteins for germ-line development are stored in polar granules and are translated on the polysomes developed on the surface of polar granules (37). Further analysis to test the possibility that mtlrRNA is involved in protein synthesis on polar granules will give a better understanding of molecular basis for pole cell formation.
Organelles comparable to polar granules have been found in the germ line of many animal groups (1, 2), suggesting that they have widespread roles in germ-line development. More importantly, the extra-mitochondrial mtlrRNA is a common component of the germinal granules in Drosophila and Xenopus (38). We propose that mtlrRNA participates in a conserved mechanism of germ-line development among metazoans.
Acknowledgments
We thank L. Pick for her gift of pGEM7Zf(−) vector; R. E. Boswell, A. Nakamura, and P. F. Lasko for antibodies; A. Ephrussi for osk and bcd cDNAs; A. Ohkawa and K. Taira for valuable comments on ribozyme technique; R. Amikura for help in electron microscopy; and P. F. Lasko and members of the Kobayashi laboratory for helpful comments on the manuscript. This work was supported in part by a grant-in-aid from the Ministry of Education, Science and Culture, Japan, the Tsukuba Advanced Research Alliance-Project, the Toray Science Foundation, the Sumitomo Foundation, and a Research Project for Future Program from Japan Society for the Promotion of Science.
ABBREVIATIONS
- mtlrRNA
mitochondrially encoded large ribosomal RNA
- DW
distilled water
- DIG
digoxigenin
References
- 1.Beams H W, Kessel R G. Int Rev Cytol. 1974;39:413–479. doi: 10.1016/s0074-7696(08)60944-4. [DOI] [PubMed] [Google Scholar]
- 2.Eddy E M. Int Rev Cytol. 1975;43:229–280. doi: 10.1016/s0074-7696(08)60070-4. [DOI] [PubMed] [Google Scholar]
- 3.Illmensee K, Mahowald A P. Proc Natl Acad Sci USA. 1974;71:1016–1020. doi: 10.1073/pnas.71.4.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Illmensee K, Mahowald A P. Exp Cell Res. 1976;97:127–140. doi: 10.1016/0014-4827(76)90662-5. [DOI] [PubMed] [Google Scholar]
- 5.Ikenishi K, Nakazato S, Okuda T. Dev Growth Differ. 1986;28:585–590. doi: 10.1111/j.1440-169X.1986.00563.x. [DOI] [PubMed] [Google Scholar]
- 6.Technau G M, Campos-Ortega J A. Wilhelm Roux Arch Dev Biol. 1986;195:489–498. doi: 10.1007/BF00375889. [DOI] [PubMed] [Google Scholar]
- 7.Mahowald A P. J Exp Zool. 1971;176:345–352. doi: 10.1002/jez.1401760309. [DOI] [PubMed] [Google Scholar]
- 8.Breitwieser W, Markussen F, Horstmann H, Ephrussi A. Genes Dev. 1996;10:2179–2188. doi: 10.1101/gad.10.17.2179. [DOI] [PubMed] [Google Scholar]
- 9.Hay B, Ackerman L, Barbel S, Jan L Y, Jan Y N. Development (Cambridge, UK) 1988;103:625–640. doi: 10.1242/dev.103.4.625. [DOI] [PubMed] [Google Scholar]
- 10.Bardsley A, McDonald K, Boswell R E. Development (Cambridge, UK) 1993;119:207–219. doi: 10.1242/dev.119.1.207. [DOI] [PubMed] [Google Scholar]
- 11.Lehmann R, Nüsslein-Volhard C. Cell. 1986;47:141–152. doi: 10.1016/0092-8674(86)90375-2. [DOI] [PubMed] [Google Scholar]
- 12.Schüpbach T, Wieshaus E. Wilhelm Roux Arch Dev Biol. 1986;195:302–317. doi: 10.1007/BF00376063. [DOI] [PubMed] [Google Scholar]
- 13.Boswell R E, Mahowald A P. Cell. 1985;43:97–104. doi: 10.1016/0092-8674(85)90015-7. [DOI] [PubMed] [Google Scholar]
- 14.Mahowald A P. J Exp Zool. 1962;151:201–215. [Google Scholar]
- 15.Kobayashi S, Amikura R, Okada M. Science. 1993;260:1521–1524. doi: 10.1126/science.7684857. [DOI] [PubMed] [Google Scholar]
- 16.Amikura R, Kobayashi S, Saito H, Okada M. Dev Growth Differ. 1996;38:489–498. doi: 10.1046/j.1440-169X.1996.t01-4-00005.x. [DOI] [PubMed] [Google Scholar]
- 17.Ding D, Whittaker K L, Lipshitz H D. Dev Biol. 1994;163:503–515. doi: 10.1006/dbio.1994.1166. [DOI] [PubMed] [Google Scholar]
- 18.Kobayashi S, Okada M. Development (Cambridge, UK) 1989;107:733–742. doi: 10.1242/dev.107.4.733. [DOI] [PubMed] [Google Scholar]
- 19.Lieber A, Kay M A. J Virol. 1996;70:3153–3158. doi: 10.1128/jvi.70.5.3153-3158.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Haseloff J, Gerlash W L. Nature (London) 1988;334:585–591. doi: 10.1038/334585a0. [DOI] [PubMed] [Google Scholar]
- 21.Efrat S, Leiser M, Wu Y-J, Fusco-DeMane D, Emran O A, Surana M, Jetton T L, Magnuson M A, Weir G, Fleishcer N. Proc Natl Acad Sci USA. 1994;91:2051–2055. doi: 10.1073/pnas.91.6.2051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Larsson S, Hotchkiss G, Andäng M, Nyholm T, Inzunza J, Jansson I, Ährlund-Richter L. Nucleic Acids Res. 1994;22:2242–2248. doi: 10.1093/nar/22.12.2242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lyngstadaas S P, Risnes S, Sproat B S, Thrane P S, Prydz H P. EMBO J. 1995;14:5224–5229. doi: 10.1002/j.1460-2075.1995.tb00207.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Marusic L, Luzi E, Barsacchi G, Eckstein F. Eur J Biochem. 1997;247:396–401. doi: 10.1111/j.1432-1033.1997.00396.x. [DOI] [PubMed] [Google Scholar]
- 25.Vanario-Alonso C E, O’Hara E, McGinnis W, Pick L. Mech Dev. 1995;53:323–328. doi: 10.1016/0925-4773(95)00448-3. [DOI] [PubMed] [Google Scholar]
- 26.Heinrich J C, Tabler M, Louis C. Anti Res Dev. 1995;5:155–160. doi: 10.1089/ard.1995.5.155. [DOI] [PubMed] [Google Scholar]
- 27.Adams M D, Tarng R S, Rio D C. Genes Dev. 1997;11:129–138. doi: 10.1101/gad.11.1.129. [DOI] [PubMed] [Google Scholar]
- 28.Sternbach O C, Wolffe A P, Rupp R A W. Nature (London) 1997;389:395–399. doi: 10.1038/38755. [DOI] [PubMed] [Google Scholar]
- 29.Xie Y, Chen X, Wagner T E. Proc Natl Acad Sci USA. 1997;94:13777–13781. doi: 10.1073/pnas.94.25.13777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhao J J, Pick L. Nature (London) 1993;365:448–451. doi: 10.1038/365448a0. [DOI] [PubMed] [Google Scholar]
- 31.Kobayashi S, Okada M. Nucleic Acids Res. 1990;18:4592. doi: 10.1093/nar/18.15.4592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Okada M, Kleinman I A, Schneiderman H A. Dev Biol. 1974;37:43–54. doi: 10.1016/0012-1606(74)90168-7. [DOI] [PubMed] [Google Scholar]
- 33.Amikura R, Kobayashi S, Endo K, Okada M. Dev Growth Differ. 1993;35:617–623. doi: 10.1111/j.1440-169X.1993.00617.x. [DOI] [PubMed] [Google Scholar]
- 34.Tautz D, Preifle C. Chromosoma. 1989;98:81–85. doi: 10.1007/BF00291041. [DOI] [PubMed] [Google Scholar]
- 35.Kobayashi S, Amikura R, Nakamura A, Lasko P F. In: Advances in Molecular Biology: A Comparative Methods Approach to the Study of Oocytes and Embryos. Richter J, editor. New York: Oxford Univ. Press; 1998. , in press. [Google Scholar]
- 36.Jongens T A, Hay B, Jan L Y, Jan Y N. Cell. 1992;70:569–584. doi: 10.1016/0092-8674(92)90427-e. [DOI] [PubMed] [Google Scholar]
- 37.Mahowald A P. J Exp Zool. 1968;167:237–262. doi: 10.1002/jez.1401670211. [DOI] [PubMed] [Google Scholar]
- 38.Kobayashi S, Amikura R, Okada M. Int J Dev Biol. 1994;38:193–199. [PubMed] [Google Scholar]
- 39.Frigerio G, Burri M, Bopp D, Baumgartner S, Noll M. Cell. 1986;47:735–746. doi: 10.1016/0092-8674(86)90516-7. [DOI] [PubMed] [Google Scholar]
- 40.Berleth T, Burri M, Thoma G, Bopp D, Richstein S, Frigerio G, Noll M, Nüsslein-Volhard C. EMBO J. 1988;7:1749–1756. doi: 10.1002/j.1460-2075.1988.tb03004.x. [DOI] [PMC free article] [PubMed] [Google Scholar]